


1. 1-(4-(4-(4-hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-d)pyridazin-2-yl)-piperidin-4-yl-acetonitrile
2. 4-piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-
3. Asn-002
4. Asn002
1. Asn002
2. Asn-002
3. 1425381-60-7
4. Gusacitinib [inn]
5. Gusacitinib [usan]
6. En3351
7. 4801qyw816
8. En-3351
9. 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6h-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile
10. 1-(4-(4-(4-hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-d)pyridazin-2-yl)-piperidin-4-yl-acetonitrile
11. 4-piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-
12. Gusacitinib (usan/inn)
13. Gusacitinib [who-dd]
14. Chembl4594275
15. Schembl14717111
16. Unii-4801qyw816
17. Gtpl10000
18. Asn-002asn-002
19. Bcp31675
20. Ex-a2668
21. Nsc818003
22. Who 10976
23. Nsc-818003
24. Example 189 [wo2013028818a1]
25. Hy-103018
26. Asn-002; Asn 002; Asn002
27. Cs-0023113
28. D11676
29. F78024
30. 2-(1-(4-((4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5-oxo-5,6-dihydropyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile
| Molecular Weight | 460.5 g/mol |
|---|---|
| Molecular Formula | C24H28N8O2 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 460.23352217 g/mol |
| Monoisotopic Mass | 460.23352217 g/mol |
| Topological Polar Surface Area | 130 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 775 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |